• Explore /
  • Poster
  • / CA209-9JC: A phase II study of first-line nivolumab (NIVO) in patients (pts) with locally advanced or metastatic cutaneous squamous cell carcinoma.

CA209-9JC: A phase II study of first-line nivolumab (NIVO) in patients (pts) with locally advanced or metastatic cutaneous squamous cell carcinoma.

Abstract Video & Slides Poster

Authors

Rodrigo Munhoz

Rodrigo Ramella Munhoz

Hospital Sírio Libanês, São Paulo, Brazil

Rodrigo Ramella Munhoz , Veridiana Pires De Camargo , Guilherme N Marta , Jade Cury Martins , Mirella Nardo , Caroline Chaul Barbosa , Carina Echer de Souza , Ingrid Barbosa , Herminia Ricci , Marcela Rodrigues de Mattos , Thiago Menezes , Guilherme Urano Machado , Eduardo Bertolli , Milton Jose Barros , Fabio A. Franke , Olavo Feher , Gilberto Castro Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03834233

Citation

J Clin Oncol 38: 2020 (suppl; abstr 10044)

DOI

10.1200/JCO.2020.38.15_suppl.10044

Abstract #

10044

Poster Bd #

393

Abstract Disclosures

Similar Posters

First Author: Eve Maubec

First Author: Salah-Eddin Al-Batran

First Author: Kelsey Klute

First Author: Guillermo de Velasco